TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Novo Nordisk A/S
Closing information (x1000 EUR)
Closing information | 2016/12 (consolidated) | 2015/12 (consolidated) | 2014/12 (consolidated) |
Turnover |
15,035,511
|
14,463,161
|
11,928,114 |
Financial expenses |
97,654
|
810,217
|
75,620 |
Earnings before taxes |
6,429,302
|
5,827,102
|
4,579,656 |
Total assets |
13,119,956
|
12,301,868
|
10,350,700 |
Current assets |
8,039,115
|
7,389,242
|
6,217,915 |
Current liabilities |
6,380,609
|
5,477,339
|
4,524,990 |
Equity capital |
6,089,126
|
6,294,256
|
5,412,150 |
- share capital |
68,600
|
69,685
|
71,188 |
Employees (average) |
42,446
|
41,122
|
40,164 |
Financial ratios
Fiscal year | 2016/12 (consolidated) | 2015/12 (consolidated) | 2014/12 (consolidated) |
Solvency |
46.4%
|
51.2%
|
52.3% |
Turnover per employee |
354
|
352
|
297 |
Profit as a percentage of turnover |
42.8%
|
40.3%
|
38.4% |
Return on assets (ROA) |
49.7%
|
54.0%
|
45.0% |
Current ratio |
126.0%
|
134.9%
|
137.4% |
Return on equity (ROE) |
105.6%
|
92.6%
|
84.6% |
Change turnover |
518,266
|
2,562,381
|
703,013 |
Change turnover % |
4%
|
22%
|
6% |
Chg. No. of employees |
1,324
|
958
|
4,020 |
Chg. No. of employees % |
3%
|
2%
|
11% |
Total value of public sale
Fiscal year | 2016/12 (consolidated) | 2015/12 (consolidated) | 2014/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.